TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s4188-4.18%decrease; red down pointing triangle pharmaceutical business for more than $3 billion, a deal that would allow the ...

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...

Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") ...

Bain Capital announced today it will acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group in a deal valued at 510 billion yen ($3.3 billion). The acquisition will transform Tanabe Pharma, ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

Founded in 1678, Tanabe Pharma is headquartered in Doshomachi, Osaka Bain Capital has made over 37 investments in Japan since establishing its Tokyo office in 2006 The transaction is expected to ...

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment TOKYO & ...